Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Olga O. Pozdnyakova, Ph.D., M.D.

Title
Institution
Department
Address
Phone

Bibliographic
selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Chen EC, Gandler H, Tošic I, Fell GG, Fiore A, Pozdnyakova O, DeAngelo DJ, Galinsky I, Luskin MR, Wadleigh M, Winer ES, Leonard R, O'Day K, de Jonge A, Neuberg D, Look AT, Stone RM, Frank DA, Garcia JS. Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates. Clin Cancer Res. 2023 Mar 01; 29(5):878-887. PMID: 36534523.
    Citations:    Fields:    
  2. Siddiqui M, Konoplev S, Issa G, Kantarjian H, Daver N, Ravandi F, Kadia T, Tang G, Wang SA, Thakral B, Medeiros LJ, Pozdnyakova O, Pierce S, Montalban-Bravo G, Chien K, Hammond D, Sasaki K, Garcia-Manero G, Hasserjian RP. Biologic features and clinical outcomes in newly diagnosed myelodysplastic syndrome with KMT2A rearrangements. Am J Hematol. 2023 Jan 20. PMID: 36661399.
    Citations:    Fields:    
  3. Jutzi JS, Marneth AE, Jiménez-Santos MJ, Hem J, Guerra-Moreno A, Rolles B, Bhatt S, Myers SA, Carr SA, Hong Y, Pozdnyakova O, van Galen P, Al-Shahrour F, Nam AS, Mullally A. CALR-mutated cells are vulnerable to combined inhibition of the proteasome and the endoplasmic reticulum stress response. Leukemia. 2023 02; 37(2):359-369. PMID: 36473980.
    Citations:    Fields:    Translation:HumansCells
  4. Miller PG, Fell GG, Foy BH, Scherer AK, Gibson CJ, Sperling AS, Burugula BB, Nakao T, Uddin MM, Warren H, Bry L, Pozdnyakova O, Frigault MJ, Bick AG, Neuberg D, Higgins JM, Mansour MK, Natarajan P, Kim AS, Kitzman JO, Ebert BL. Clonal hematopoiesis of indeterminate potential and risk of death from COVID-19. Blood. 2022 11 03; 140(18):1993-1997. PMID: 36096050; PMCID: PMC9474399.
    Citations:    Fields:    Translation:Humans
  5. Wright MF, Pozdnyakova O, Hasserjian RP, Aggarwal N, Shaver AC, Weinberg OK, Irlmeier R, Koyama T, Seegmiller AC, Strickland SA, Mason EF. Secondary-type mutations do not impact prognosis in acute myelogenous leukemia AML with mutated NPM1. Am J Hematol. 2022 12; 97(12):E462-E465. PMID: 36106410.
    Citations: 1     Fields:    Translation:Humans
  6. Vining KH, Marneth AE, Adu-Berchie K, Grolman JM, Tringides CM, Liu Y, Wong WJ, Pozdnyakova O, Severgnini M, Stafford A, Duda GN, Hodi FS, Mullally A, Wucherpfennig KW, Mooney DJ. Mechanical checkpoint regulates monocyte differentiation in fibrotic niches. Nat Mater. 2022 08; 21(8):939-950. PMID: 35817965.
    Citations:    Fields:    
  7. Pozdnyakova O, Niculescu RS, Kroll T, Golemme L, Raymond N, Briggs D, Kim A. Beyond the routine CBC: machine learning and statistical analyses identify research CBC parameter associations with myelodysplastic syndromes and specific underlying pathogenic variants. J Clin Pathol. 2022 May 16. PMID: 35577566.
    Citations:    Fields:    
  8. Kanagal-Shamanna R, Orazi A, Hasserjian RP, Arber DA, Reichard K, Hsi ED, Bagg A, Rogers HJ, Geyer J, Darbaniyan F, Do KA, Devins KM, Pozdnyakova O, George TI, Cin PD, Greipp PT, Routbort MJ, Patel K, Garcia-Manero G, Verstovsek S, Medeiros LJ, Wang SA, Bueso-Ramos C. Correction to: Myelodysplastic/myeloproliferative neoplasms-unclassifiable with isolated isochromosome 17q represents a distinct clinico-biologic subset: a multi-institutional collaborative study from the Bone Marrow Pathology Group. Mod Pathol. 2022 May; 35(5):705. PMID: 34903824.
    Citations:    Fields:    
  9. Ho VT, Kim HT, Brock J, Galinsky I, Daley H, Reynolds C, Weber A, Pozdnyakova O, Severgnini M, Nikiforow S, Cutler C, Koreth J, Alyea EP, Antin JH, Gooptu M, Romee R, Shapiro R, Chen YB, Rosenblatt J, Avigan D, Hodi FS, Dranoff G, Wu CJ, Ritz J, Soiffer RJ. GM-CSF secreting leukemia cell vaccination for MDS/AML after allogeneic HSCT: a randomized, double-blinded, phase 2 trial. Blood Adv. 2022 04 12; 6(7):2183-2194. PMID: 34807983; PMCID: PMC9006263.
    Citations:    Fields:    Translation:HumansPHPublic HealthCTClinical Trials
  10. Kim AS, Pozdnyakova O. SOHO State of the Art Updates and Next Questions | Myeloid/Lymphoid Neoplasms with Eosinophilia and Gene Rearrangements: Diagnostic Pearls and Pitfalls. Clin Lymphoma Myeloma Leuk. 2022 09; 22(9):643-651. PMID: 35478091.
    Citations:    Fields:    
  11. Pozdnyakova O. NPM1: not present? Mark! Blood. 2021 12 23; 138(25):2602-2603. PMID: 34940821.
    Citations:    Fields:    Translation:Humans
  12. Kanagal-Shamanna R, Orazi A, Hasserjian RP, Arber DA, Reichard K, Hsi ED, Bagg A, Rogers HJ, Geyer J, Darbaniyan F, Do KA, Devins KM, Pozdnyakova O, George TI, Cin PD, Greipp PT, Routbort MJ, Patel K, Garcia-Manero G, Verstovsek S, Medeiros LJ, Wang SA, Bueso-Ramos C. Myelodysplastic/myeloproliferative neoplasms-unclassifiable with isolated isochromosome 17q represents a distinct clinico-biologic subset: a multi-institutional collaborative study from the Bone Marrow Pathology Group. Mod Pathol. 2022 04; 35(4):470-479. PMID: 34775472; PMCID: PMC8967812.
    Citations:    Fields:    Translation:HumansCells
  13. Lucas F, Stecker MS, Pozdnyakova O, Connors JM, Battinelli EM. Rivaroxaban-calibrated chromogenic anti-Xa assay in cirrhosis: Use to rule out disseminated intravascular coagulation. Res Pract Thromb Haemost. 2021 Oct; 5(7):e12594. PMID: 34646974.
    Citations:    
  14. Katz BZ, Feldman MD, Tessema M, Benisty D, Toles GS, Andre A, Shtreker B, Paz FM, Edwards J, Jengehino D, Bagg A, Avivi I, Pozdnyakova O. Evaluation of Scopio Labs X100 Full Field PBS: The first high-resolution full field viewing of peripheral blood specimens combined with artificial intelligence-based morphological analysis. Int J Lab Hematol. 2021 Dec; 43(6):1408-1416. PMID: 34546630; PMCID: PMC9293172.
    Citations: 2     Fields:    Translation:HumansCells
  15. Castillo JJ, LaMacchia J, Flynn CA, Sarosiek S, Pozdnyakova O, Treon SP. Plasmablastic lymphoma transformation in a patient with Waldenström macroglobulinemia treated with ibrutinib. Br J Haematol. 2021 11; 195(3):466-468. PMID: 34355802.
    Citations:    Fields:    Translation:Humans
  16. Hamilton MJ, Zhao M, Giannetti MP, Weller E, Hufdhi R, Novak P, Mendoza-Alvarez LB, Hornick J, Lyons JJ, Glover SC, Castells MC, Pozdnyakova O. Distinct Small Intestine Mast Cell Histologic Changes in Patients With Hereditary Alpha-tryptasemia and Mast Cell Activation Syndrome. Am J Surg Pathol. 2021 07 01; 45(7):997-1004. PMID: 33481382; PMCID: PMC8192345.
    Citations: 4     Fields:    Translation:HumansCells
  17. Narayanan D, Pozdnyakova O, Hasserjian RP, Patel SS, Weinberg OK. Effect of DNMT3A variant allele frequency and double mutation on clinicopathologic features of patients with de novo AML. Blood Adv. 2021 06 08; 5(11):2539-2549. PMID: 34100902; PMCID: PMC8238486.
    Citations: 1     Fields:    Translation:Humans
  18. Mason EF, Pozdnyakova O, Roshal M, Fathi AT, Stein EM, Ferrell PB, Shaver AC, Frattini M, Wang H, Hua L, Mu J, Choe S, Xu R, Almon C, Cooper M, Stone RM, Hasserjian RP, Savona MR. A novel differentiation response with combination IDH inhibitor and intensive induction therapy for AML. Blood Adv. 2021 04 27; 5(8):2279-2283. PMID: 33904894; PMCID: PMC8095142.
    Citations: 1     Fields:    Translation:Humans
  19. Hergott CB, Pozdnyakova O. Beware the "other AML": hepatic angiomyolipoma with extensive extramedullary hematopoiesis. Blood. 2021 02 11; 137(6):860. PMID: 33570613.
    Citations:    Fields:    Translation:Humans
  20. Pozdnyakova O, Connell NT, Battinelli EM, Connors JM, Fell G, Kim AS. Clinical Significance of CBC and WBC Morphology in the Diagnosis and Clinical Course of COVID-19 Infection. Am J Clin Pathol. 2021 Feb 11; 155(3):364-375. PMID: 33269374; PMCID: PMC7799218.
    Citations: 13     Fields:    Translation:HumansCells
  21. Pozdnyakova O, Orazi A, Kelemen K, King R, Reichard KK, Craig FE, Quintanilla-Martinez L, Rimsza L, George TI, Horny HP, Wang SA. Myeloid/Lymphoid Neoplasms Associated With Eosinophilia and Rearrangements of PDGFRA, PDGFRB, or FGFR1 or With PCM1-JAK2. Am J Clin Pathol. 2021 02 04; 155(2):160-178. PMID: 33367495.
    Citations: 5     Fields:    Translation:Humans
  22. Miller PG, Sperling AS, Gibson CJ, Pozdnyakova O, Wong WJ, Manos MP, Buchbinder EI, Hodi FS, Ebert BL, Davids MS. A deep molecular response of splenic marginal zone lymphoma to front-line checkpoint blockade. Haematologica. 2021 02 01; 106(2):651-654. PMID: 33054119.
    Citations: 2     Fields:    Translation:Humans
  23. Narayanan D, Pozdnyakova O. Marked dysgranulopoiesis mimicking disseminated histoplasmosis. Blood. 2020 12 10; 136(24):2838. PMID: 33301038.
    Citations:    Fields:    Translation:Humans
  24. Giannetti MP, Akin C, Hufdhi R, Hamilton MJ, Weller E, van Anrooij B, Lyons JJ, Hornick JL, Pinkus G, Castells M, Pozdnyakova O. Patients with mast cell activation symptoms and elevated baseline serum tryptase level have unique bone marrow morphology. J Allergy Clin Immunol. 2021 04; 147(4):1497-1501.e1. PMID: 33248113.
    Citations: 5     Fields:    Translation:HumansCells
  25. Patel SS, Lipschitz M, Pinkus GS, Weirather JL, Pozdnyakova O, Mason EF, Inghirami G, Hasserjian RP, Rodig SJ, Weinberg OK. Multiparametric in situ imaging of NPM1-mutated acute myeloid leukemia reveals prognostically-relevant features of the marrow microenvironment. Mod Pathol. 2020 07; 33(7):1380-1388. PMID: 32051557.
    Citations: 3     Fields:    Translation:Humans
  26. Mason EF, Hasserjian RP, Aggarwal N, Seegmiller AC, Pozdnyakova O. Blast phenotype and comutations in acute myeloid leukemia with mutated NPM1 influence disease biology and outcome. Blood Adv. 2019 11 12; 3(21):3322-3332. PMID: 31698462; PMCID: PMC6855116.
    Citations: 4     Fields:    Translation:Humans
  27. Togami K, Pastika T, Stephansky J, Ghandi M, Christie AL, Jones KL, Johnson CA, Lindsay RW, Brooks CL, Letai A, Craig JW, Pozdnyakova O, Weinstock DM, Montero J, Aster JC, Johannessen CM, Lane AA. DNA methyltransferase inhibition overcomes diphthamide pathway deficiencies underlying CD123-targeted treatment resistance. J Clin Invest. 2019 11 01; 129(11):5005-5019. PMID: 31437130; PMCID: PMC6819120.
    Citations: 17     Fields:    Translation:HumansAnimalsCells
  28. Wright KT, Pozdnyakova O. Say hello to TUGSE! Blood. 2019 10 17; 134(16):1360. PMID: 31698439.
    Citations:    Fields:    Translation:Humans
  29. Nachmani D, Bothmer AH, Grisendi S, Mele A, Bothmer D, Lee JD, Monteleone E, Cheng K, Zhang Y, Bester AC, Guzzetti A, Mitchell CA, Mendez LM, Pozdnyakova O, Sportoletti P, Martelli MP, Vulliamy TJ, Safra M, Schwartz S, Luzzatto L, Bluteau O, Soulier J, Darnell RB, Falini B, Dokal I, Ito K, Clohessy JG, Pandolfi PP. Germline NPM1 mutations lead to altered rRNA 2'-O-methylation and cause dyskeratosis congenita. Nat Genet. 2019 10; 51(10):1518-1529. PMID: 31570891; PMCID: PMC6858547.
    Citations: 28     Fields:    Translation:AnimalsCells
  30. Wong WJ, Wong WJ, Baltay M, Getz A, Fuhrman K, Aster JC, Hasserjian RP, Pozdnyakova O. Gene expression profiling distinguishes prefibrotic from overtly fibrotic myeloproliferative neoplasms and identifies disease subsets with distinct inflammatory signatures. PLoS One. 2019; 14(5):e0216810. PMID: 31071164; PMCID: PMC6534080.
    Citations: 11     Fields:    Translation:HumansCTClinical Trials
  31. Gjini E, Jing CB, Nguyen AT, Reyon D, Gans E, Kesarsing M, Peterson J, Pozdnyakova O, Rodig SJ, Mansour MR, Joung K, Look AT. Disruption of asxl1 results in myeloproliferative neoplasms in zebrafish. Dis Model Mech. 2019 05 07; 12(5). PMID: 31064769; PMCID: PMC6550042.
    Citations: 5     Fields:    Translation:AnimalsCells
  32. Wong WJ, Wong WJ, Pozdnyakova O. Myeloproliferative neoplasms: Diagnostic workup of the cythemic patient. Int J Lab Hematol. 2019 May; 41 Suppl 1:142-150. PMID: 31069979.
    Citations: 2     Fields:    Translation:Humans
  33. Mugoni V, Panella R, Cheloni G, Chen M, Pozdnyakova O, Stroopinsky D, Guarnerio J, Monteleone E, Lee JD, Mendez L, Menon AV, Aster JC, Lane AA, Stone RM, Galinsky I, Zamora JC, Lo-Coco F, Bhasin MK, Avigan D, Longo L, Clohessy JG, Pandolfi PP. Vulnerabilities in mIDH2 AML confer sensitivity to APL-like targeted combination therapy. Cell Res. 2019 06; 29(6):446-459. PMID: 31024166; PMCID: PMC6796925.
    Citations: 15     Fields:    Translation:HumansAnimalsCells
  34. van Galen P, Hovestadt V, Wadsworth Ii MH, Hughes TK, Griffin GK, Battaglia S, Verga JA, Stephansky J, Pastika TJ, Lombardi Story J, Pinkus GS, Pozdnyakova O, Galinsky I, Stone RM, Graubert TA, Shalek AK, Aster JC, Lane AA, Bernstein BE. Single-Cell RNA-Seq Reveals AML Hierarchies Relevant to Disease Progression and Immunity. Cell. 2019 03 07; 176(6):1265-1281.e24. PMID: 30827681.
    Citations: 214     Fields:    Translation:HumansCells
  35. Boiocchi L, Hasserjian RP, Pozdnyakova O, Wong WJ, Wong WJ, Lennerz JK, Le LP, Dias-Santagata D, Iafrate AJ, Hobbs GS, Nardi V. Clinicopathological and molecular features of SF3B1-mutated myeloproliferative neoplasms. Hum Pathol. 2019 04; 86:1-11. PMID: 30594750.
    Citations: 10     Fields:    Translation:Humans
  36. Bendapudi PK, Robbins A, LeBoeuf N, Pozdnyakova O, Bhatt A, Duke F, Sells R, McQuiston J, Humrighouse B, Rouaisnel B, Colling M, Stephenson KE, Saavedra A, Losman JA. Persistence of endothelial thrombomodulin in a patient with infectious purpura fulminans treated with protein C concentrate. Blood Adv. 2018 11 13; 2(21):2917-2921. PMID: 30396911.
    Citations: 2     Fields:    Translation:HumansCells
  37. Brunner AM, Kim PG, Sadrzadeh H, Drapkin BJ, Sprague KA, Sloan JM, Chai-Ho W, Bhargava P, Pozdnyakova O, Fathi AT. Clustered incidence of adult acute promyelocytic leukemia. Leuk Res. 2018 11; 74:47-50. PMID: 30292128.
    Citations: 1     Fields:    Translation:HumansCTClinical Trials
  38. Dannheim KC, Pozdnyakova O, Dal Cin P, Weinberg OK. Immunophenotypic dysplasia and aberrant T-cell antigen expression in acute myeloid leukaemia with complex karyotype and TP53 mutations. J Clin Pathol. 2018 Dec; 71(12):1051-1059. PMID: 30171088.
    Citations: 1     Fields:    Translation:HumansCells
  39. Patel S, Li Y, Berchuck JE, Cunningham J, Kim A, Pozdnyakova O. Did you "miss" me? A subtle case of intravascular large B-cell lymphoma. Am J Hematol. 2019 01; 94(1):162-163. PMID: 29756305.
    Citations:    Fields:    Translation:Humans
  40. Craig JW, Mina MJ, Crombie JL, LaCasce AS, Weinstock DM, Pinkus GS, Pozdnyakova O. Assessment of CD52 expression in "double-hit" and "double-expressor" lymphomas: Implications for clinical trial eligibility. PLoS One. 2018; 13(7):e0199708. PMID: 30020951.
    Citations: 1     Fields:    Translation:Humans
  41. Kim PG, Bridgham K, Chen EC, Vidula MK, Pozdnyakova O, Brunner AM, Fathi AT. Incident adverse events following therapy for acute promyelocytic leukemia. Leuk Res Rep. 2018; 9:79-83. PMID: 29892554; PMCID: PMC5993355.
    Citations: 3     
  42. Keegan A, Charest K, Schmidt R, Briggs D, Deangelo DJ, Li B, Morgan EA, Pozdnyakova O. Flow cytometric minimal residual disease assessment of peripheral blood in acute lymphoblastic leukaemia patients has potential for early detection of relapsed extramedullary disease. J Clin Pathol. 2018 Jul; 71(7):653-658. PMID: 29588374.
    Citations: 4     Fields:    Translation:HumansCells
  43. Hergott CB, Pozdnyakova O. Evans syndrome secondary to undiagnosed chronic lymphocytic leukemia in a patient with unexplained bleeding. Am J Hematol. 2018 07; 93(7):978-979. PMID: 29341268.
    Citations:    Fields:    Translation:Humans
  44. Mason EF, Kuo FC, Hasserjian RP, Seegmiller AC, Pozdnyakova O. A distinct immunophenotype identifies a subset of NPM1-mutated AML with TET2 or IDH1/2 mutations and improved outcome. Am J Hematol. 2018 08; 93(4):504-510. PMID: 29274134.
    Citations: 13     Fields:    Translation:Humans
  45. Weinberg OK, Gibson CJ, Blonquist TM, Neuberg D, Pozdnyakova O, Kuo F, Ebert BL, Hasserjian RP. Association of mutations with morphological dysplasia in de novo acute myeloid leukemia without 2016 WHO Classification-defined cytogenetic abnormalities. Haematologica. 2018 04; 103(4):626-633. PMID: 29326119; PMCID: PMC5865424.
    Citations: 6     Fields:    Translation:HumansCells
  46. Wong WJ, Hasserjian RP, Pinkus GS, Breyfogle LJ, Mullally A, Pozdnyakova O. JAK2, CALR, MPL and ASXL1 mutational status correlates with distinct histological features in Philadelphia chromosome-negative myeloproliferative neoplasms. Haematologica. 2018 02; 103(2):e63-e68. PMID: 29146710.
    Citations: 9     Fields:    Translation:HumansCells
  47. Ho VT, Kim HT, Bavli N, Mihm M, Pozdnyakova O, Piesche M, Daley H, Reynolds C, Souders NC, Cutler C, Koreth J, Alyea EP, Antin JH, Ritz J, Dranoff G, Soiffer RJ. Vaccination with autologous myeloblasts admixed with GM-K562 cells in patients with advanced MDS or AML after allogeneic HSCT. Blood Adv. 2017 Nov 14; 1(24):2269-2279. PMID: 29296875.
    Citations: 5     Fields:    
  48. Shanmugam V, Craig JW, Hornick JL, Morgan EA, Pinkus GS, Pozdnyakova O. Cyclin D1 Is Expressed in Neoplastic Cells of Langerhans Cell Histiocytosis but Not Reactive Langerhans Cell Proliferations. Am J Surg Pathol. 2017 Oct; 41(10):1390-1396. PMID: 28622183.
    Citations: 11     Fields:    Translation:HumansCells
  49. Rosenbaum MW, Pozdnyakova O, Geyer JT, Dal Cin P, Hasserjian RP. Ring chromosome in myeloid neoplasms is associated with complex karyotype and disease progression. Hum Pathol. 2017 10; 68:40-46. PMID: 28842184.
    Citations: 2     Fields:    Translation:HumansCells
  50. Mason EF, Pozdnyakova O, Li B, Dudley G, Dorfman DM. Flow Cytometric Patterns of CD200 and CD1d Expression Distinguish CD10-Negative, CD5-Negative Mature B-Cell Lymphoproliferative Disorders. Am J Clin Pathol. 2017 Jul 01; 148(1):33-41. PMID: 28575142.
    Citations: 3     Fields:    Translation:HumansCells
  51. Weinberg OK, Gibson CJ, Blonquist TM, Neuberg D, Pozdnyakova O, Kuo F, Ebert BL, Hasserjian RP. NPM1 mutation but not RUNX1 mutation or multilineage dysplasia defines a prognostic subgroup within de novo acute myeloid leukemia lacking recurrent cytogenetic abnormalities in the revised 2016 WHO classification. Am J Hematol. 2017 Jul; 92(7):E123-E124. PMID: 28370403; PMCID: PMC5470583.
    Citations: 3     Fields:    Translation:Humans
  52. Mason EF, Morgan EA, Pinkus GS, Pozdnyakova O. Cost-effective approach to the diagnostic workup of B cell lymphoproliferative disorders via optimal integration of flow cytometric data. Int J Lab Hematol. 2017 Apr; 39(2):137-146. PMID: 28133951.
    Citations: 2     Fields:    Translation:HumansCells
  53. Wang SA, Patel KP, Pozdnyakova O, Peng J, Zuo Z, Dal Cin P, Steensma DP, Hasserjian RP. Acute erythroid leukemia with <20% bone marrow blasts is clinically and biologically similar to myelodysplastic syndrome with excess blasts. Mod Pathol. 2016 10; 29(10):1221-31. PMID: 27443511.
    Citations: 5     Fields:    Translation:Humans
  54. Weinberg OK, Hasserjian RP, Li B, Pozdnyakova O. Assessment of myeloid and monocytic dysplasia by flow cytometry in de novo AML helps define an AML with myelodysplasia-related changes category. J Clin Pathol. 2017 Feb; 70(2):109-115. PMID: 27387988.
    Citations: 1     Fields:    Translation:HumansCells
  55. Petrova-Drus K, Hasserjian R, Pozdnyakova O, Dal Cin P, Mathew S, Margolskee E, Orazi A, Geyer JT. Clinicopathologic evaluation of cytopenic patients with isolated trisomy 8: a detailed comparison between idiopathic cytopenia of unknown significance and low-grade myelodysplastic syndrome. Leuk Lymphoma. 2017 03; 58(3):569-577. PMID: 27389864.
    Citations: 4     Fields:    Translation:HumansCells
  56. Hwang DH, Dorfman DM, Hwang DG, Senna P, Pozdnyakova O. Automated Nucleated RBC Measurement Using the Sysmex XE-5000 Hematology Analyzer: Frequency and Clinical Significance of the Nucleated RBCs. Am J Clin Pathol. 2016 Mar; 145(3):379-84. PMID: 26834126.
    Citations: 2     Fields:    Translation:HumansCells
  57. Dorfman DM, LaPlante CD, Pozdnyakova O, Li B. FLOCK cluster analysis of mast cell event clustering by high-sensitivity flow cytometry predicts systemic mastocytosis. Am J Clin Pathol. 2015 Nov; 144(5):764-70. PMID: 26486741.
    Citations: 2     Fields:    Translation:HumansCells
  58. Till BG, Li H, Bernstein SH, Fisher RI, Burack WR, Rimsza LM, Floyd JD, DaSilva MA, Moore DF, Pozdnyakova O, Smith SM, LeBlanc M, Friedberg JW. Phase II trial of R-CHOP plus bortezomib induction therapy followed by bortezomib maintenance for newly diagnosed mantle cell lymphoma: SWOG S0601. Br J Haematol. 2016 Jan; 172(2):208-18. PMID: 26492567; PMCID: PMC4710555.
    Citations: 23     Fields:    Translation:HumansCTClinical Trials
  59. Kluk MJ, Abo RP, Brown RD, Kuo FC, Dal Cin P, Pozdnyakova O, Morgan EA, Lindeman NI, DeAngelo DJ, Aster JC. Myeloid neoplasm demonstrating a STAT5B-RARA rearrangement and genetic alterations associated with all-trans retinoic acid resistance identified by a custom next-generation sequencing assay. Cold Spring Harb Mol Case Stud. 2015 Oct; 1(1):a000307. PMID: 27148563.
    Citations: 5     Fields:    
  60. Weinberg OK, Rodig SJ, Pozdnyakova O, Ren L, Arber DA, Ohgami RS. Surface Light Chain Expression in Primary Mediastinal Large B-Cell Lymphomas by Multiparameter Flow Cytometry. Am J Clin Pathol. 2015 Oct; 144(4):635-41. PMID: 26386085.
    Citations:    Fields:    Translation:Humans
  61. Jamieson C, Hasserjian R, Gotlib J, Cortes J, Stone R, Talpaz M, Thiele J, Rodig S, Pozdnyakova O. Effect of treatment with a JAK2-selective inhibitor, fedratinib, on bone marrow fibrosis in patients with myelofibrosis. J Transl Med. 2015 Sep 10; 13:294. PMID: 26357842; PMCID: PMC4566296.
    Citations: 17     Fields:    Translation:HumansCellsCTClinical Trials
  62. Huck A, Pozdnyakova O, Brunner A, Higgins JM, Fathi AT, Hasserjian RP. Prior cytopenia predicts worse clinical outcome in acute myeloid leukemia. Leuk Res. 2015 Oct; 39(10):1034-40. PMID: 26220865; PMCID: PMC5764101.
    Citations: 3     Fields:    Translation:Humans
  63. Weinberg OK, Pozdnyakova O, Campigotto F, DeAngelo DJ, Stone RM, Neuberg D, Hasserjian RP. Reproducibility and prognostic significance of morphologic dysplasia in de novo acute myeloid leukemia. Mod Pathol. 2015 Jul; 28(7):965-76. PMID: 25975285.
    Citations: 9     Fields:    Translation:HumansCells
  64. Pozdnyakova O, Hasserjian RP, Verstovsek S, Orazi A. Impact of bone marrow pathology on the clinical management of Philadelphia chromosome-negative myeloproliferative neoplasms. Clin Lymphoma Myeloma Leuk. 2015 May; 15(5):253-61. PMID: 25515354.
    Citations: 6     Fields:    Translation:HumansCells
  65. Pozdnyakova O, Laplante CD, Li B, Rosner B, Dorfman DM. High-sensitivity flow cytometric analysis of mast cell clustering in systemic mastocytosis: a quantitative and statistical analysis. Leuk Lymphoma. 2015 Jun; 56(6):1735-41. PMID: 25284492.
    Citations:    Fields:    Translation:HumansCells
  66. Pozdnyakova O, Rodig S, Bhandarkar S, Wu K, Thiele J, Hasserjian R. The importance of central pathology review in international trials: a comparison of local versus central bone marrow reticulin grading. Leukemia. 2015 Jan; 29(1):241-4. PMID: 25183285.
    Citations: 5     Fields:    Translation:Humans
  67. Jacobsen E, Pozdnyakova O, Redd R, Fisher DC, Dorfman DM, Dal Cin P, LaCasce A, Armand P, Hochberg E, Cote G, Shahsafaei A, Neuberg D, Brown JR, Freedman AS. Imatinib mesylate lacks efficacy in relapsed/refractory peripheral T cell lymphoma. Leuk Lymphoma. 2015 Apr; 56(4):993-8. PMID: 25012943.
    Citations: 1     Fields:    Translation:HumansCTClinical Trials
  68. Pozdnyakova O, Wu K, Patki A, Rodig SJ, Thiele J, Hasserjian RP. High concordance in grading reticulin fibrosis and cellularity in patients with myeloproliferative neoplasms. Mod Pathol. 2014 Nov; 27(11):1447-54. PMID: 24762543.
    Citations: 11     Fields:    Translation:Humans
  69. Mandelker DL, Dorfman DM, Li B, Pozdnyakova O. Antigen expression patterns of MYC-rearranged versus non-MYC-rearranged B-cell lymphomas by flow cytometry. Leuk Lymphoma. 2014 Nov; 55(11):2592-6. PMID: 24397618.
    Citations: 1     Fields:    Translation:Humans
  70. Kats LM, Reschke M, Taulli R, Pozdnyakova O, Burgess K, Bhargava P, Straley K, Karnik R, Meissner A, Small D, Su SM, Yen K, Zhang J, Pandolfi PP. Proto-oncogenic role of mutant IDH2 in leukemia initiation and maintenance. Cell Stem Cell. 2014 Mar 06; 14(3):329-41. PMID: 24440599.
    Citations: 99     Fields:    Translation:AnimalsCells
  71. Bachireddy P, Hainz U, Rooney M, Pozdnyakova O, Aldridge J, Zhang W, Liao X, Hodi FS, O'Connell K, Haining WN, Goldstein NR, Canning CM, Soiffer RJ, Ritz J, Hacohen N, Alyea EP, Kim HT, Wu CJ. Reversal of in situ T-cell exhaustion during effective human antileukemia responses to donor lymphocyte infusion. Blood. 2014 Feb 27; 123(9):1412-21. PMID: 24357730; PMCID: PMC3938152.
    Citations: 31     Fields:    Translation:HumansCells
  72. Pozdnyakova O, Dorfman DM. Sysmex XE-5000 blast Q flag analysis. Am J Clin Pathol. 2013 Dec; 140(6):918-9. PMID: 24225762.
    Citations:    Fields:    Translation:Humans
  73. Pillai V, Pozdnyakova O, Charest K, Li B, Shahsafaei A, Dorfman DM. CD200 flow cytometric assessment and semiquantitative immunohistochemical staining distinguishes hairy cell leukemia from hairy cell leukemia-variant and other B-cell lymphoproliferative disorders. Am J Clin Pathol. 2013 Oct; 140(4):536-43. PMID: 24045551.
    Citations: 13     Fields:    Translation:HumansCells
  74. Pozdnyakova O, Dorfman DM. The authors' reply. Am J Clin Pathol. 2013 Mar; 139(3):406-7. PMID: 23547321.
    Citations:    Fields:    Translation:Humans
  75. Pozdnyakova O, Dorfman DM. Human granulocytic anaplasmosis. Blood. 2012 Dec 13; 120(25):4911. PMID: 23367517.
    Citations: 2     Fields:    Translation:HumansCells
  76. Morgan EA, Pozdnyakova O, Nascimento AF, Hirsch MS. PAX8 and PAX5 are differentially expressed in B-cell and T-cell lymphomas. Histopathology. 2013 Feb; 62(3):406-13. PMID: 23163626.
    Citations: 8     Fields:    Translation:Humans
  77. Pozdnyakova O, Kondtratiev S, Li B, Charest K, Dorfman DM. High-sensitivity flow cytometric analysis for the evaluation of systemic mastocytosis including the identification of a new flow cytometric criterion for bone marrow involvement. Am J Clin Pathol. 2012 Sep; 138(3):416-24. PMID: 22912359.
    Citations: 1     Fields:    Translation:HumansCells
  78. Pozdnyakova O, Morgan EA, Li B, Shahsafaei A, Dorfman DM. Patterns of expression of CD56 and CD117 on neoplastic plasma cells and association with genetically distinct subtypes of plasma cell myeloma. Leuk Lymphoma. 2012 Oct; 53(10):1905-10. PMID: 22423624.
    Citations: 9     Fields:    Translation:Humans
  79. Pozdnyakova O, Kutok JL, Rodig SJ. Emerging targeted therapies for lymphoid malignancies. Arch Pathol Lab Med. 2012 May; 136(5):476-82. PMID: 22188200.
    Citations:    Fields:    Translation:Humans
  80. Pozdnyakova O, Spieler PJ, Abraham J, Freedman AS, Kutok JL. Epstein-barr virus-associated diffuse large B-cell lymphoma in an immunocompetent woman. J Clin Oncol. 2010 Feb 10; 28(5):e75-8. PMID: 19917837.
    Citations: 3     Fields:    Translation:HumansCells
  81. Pozdnyakova O, Hoang MM, Dresser KA, Mahalingam M. Prognostic value of E-cadherin, beta-catenin, CD44v6, and HER2/neu in metastatic cutaneous adenocarcinoma. Arch Pathol Lab Med. 2009 Aug; 133(8):1285-90. PMID: 19653727.
    Citations: 1     Fields:    Translation:Humans
  82. Pozdnyakova O, Grossman J, Barbagallo B, Lyle S. The hair follicle barrier to involvement by malignant melanoma. Cancer. 2009 Mar 15; 115(6):1267-75. PMID: 19152437.
    Citations: 6     Fields:    Translation:Humans
  83. Pozdnyakova O, Crowley-Larsen P, Zota V, Wang SA, Miron PM. Interphase FISH in plasma cell dyscrasia: increase in abnormality detection with plasma cell enrichment. Cancer Genet Cytogenet. 2009 Mar; 189(2):112-7. PMID: 19215792.
    Citations: 3     Fields:    Translation:HumansCells
  84. Pozdnyakova O, Miron PM, Tang G, Walter O, Raza A, Woda B, Wang SA. Cytogenetic abnormalities in a series of 1,029 patients with primary myelodysplastic syndromes: a report from the US with a focus on some undefined single chromosomal abnormalities. Cancer. 2008 Dec 15; 113(12):3331-40. PMID: 18988232.
    Citations: 24     Fields:    Translation:Humans
  85. Wang SA, Pozdnyakova O, Jorgensen JL, Medeiros LJ, Stachurski D, Anderson M, Raza A, Woda BA. Detection of paroxysmal nocturnal hemoglobinuria clones in patients with myelodysplastic syndromes and related bone marrow diseases, with emphasis on diagnostic pitfalls and caveats. Haematologica. 2009 Jan; 94(1):29-37. PMID: 19001281.
    Citations: 23     Fields:    Translation:Humans
  86. Pozdnyakova O, Mahalingam M. Involvement of the bulge region in primary scarring alopecia. J Cutan Pathol. 2008 Oct; 35(10):922-5. PMID: 18537862.
    Citations: 9     Fields:    Translation:HumansCells
  87. Pozdnyakova O, Stachurski D, Hutchinson L, Ramakrishnan S, Miron PM. Trisomy 8 in B-cell chronic lymphocytic leukemia. Cancer Genet Cytogenet. 2008 May; 183(1):49-52. PMID: 18474297.
    Citations: 2     Fields:    Translation:HumansCells
  88. Pozdnyakova O, Garg A, Mahalingam M. Nodular vasculitis - a novel cutaneous manifestation of autoimmune colitis. J Cutan Pathol. 2008 Mar; 35(3):315-9. PMID: 18251747.
    Citations: 1     Fields:    Translation:Humans
  89. Pozdnyakova O, Mahalingam M. CD99 - much ado about nothing? J Cutan Pathol. 2008 Jan; 35(1):86-7. PMID: 18096002.
    Citations:    Fields:    Translation:Humans
  90. Yue G, Hao S, Fadare O, Baker S, Pozdnyakova O, Galili N, Woda BA, Raza A, Wang SA. Hypocellularity in myelodysplastic syndrome is an independent factor which predicts a favorable outcome. Leuk Res. 2008 Apr; 32(4):553-8. PMID: 17888511.
    Citations: 11     Fields:    Translation:Humans
  91. Stachurski D, Smith BR, Pozdnyakova O, Andersen M, Xiao Z, Raza A, Woda BA, Wang SA. Flow cytometric analysis of myelomonocytic cells by a pattern recognition approach is sensitive and specific in diagnosing myelodysplastic syndrome and related marrow diseases: emphasis on a global evaluation and recognition of diagnostic pitfalls. Leuk Res. 2008 Feb; 32(2):215-24. PMID: 17675229.
    Citations: 16     Fields:    Translation:HumansCells
  92. Pozdnyakova O, Guttormsen HK, Lalani FN, Carroll MC, Kasper DL. Impaired antibody response to group B streptococcal type III capsular polysaccharide in C3- and complement receptor 2-deficient mice. J Immunol. 2003 Jan 01; 170(1):84-90. PMID: 12496386.
    Citations: 25     Fields:    Translation:AnimalsCells
  93. Barrington RA, Pozdnyakova O, Zafari MR, Benjamin CD, Carroll MC. B lymphocyte memory: role of stromal cell complement and FcgammaRIIB receptors. J Exp Med. 2002 Nov 04; 196(9):1189-99. PMID: 12417629; PMCID: PMC2194107.
    Citations: 48     Fields:    Translation:AnimalsCells
  94. Paul E, Pozdnyakova OO, Mitchell E, Carroll MC. Anti-DNA autoreactivity in C4-deficient mice. Eur J Immunol. 2002 Sep; 32(9):2672-9. PMID: 12207352.
    Citations: 26     Fields:    Translation:AnimalsCells
  95. Einav S, Pozdnyakova OO, Ma M, Carroll MC. Complement C4 is protective for lupus disease independent of C3. J Immunol. 2002 Feb 01; 168(3):1036-41. PMID: 11801636.
    Citations: 26     Fields:    Translation:AnimalsCells
  96. Prodeus AP, Goerg S, Shen LM, Pozdnyakova OO, Chu L, Alicot EM, Goodnow CC, Carroll MC. A critical role for complement in maintenance of self-tolerance. Immunity. 1998 Nov; 9(5):721-31. PMID: 9846493.
    Citations: 93     Fields:    Translation:AnimalsCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Pozdnyakova's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (383)
Explore
_
Co-Authors (111)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
© 2023 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.